News & Updates
Filter by Specialty:

Long-acting injectable HIV drug works for all ages
06 Aug 2024
byJairia Dela Cruz
The long-acting combination of cabotegravir plus rilpivirine, administered as monthly or once-every-2-months jabs, appears to be effective in both older and younger patients living with HIV, with most maintaining virologic suppression through week 96, according to pooled data from the phase III ATLAS, FLAIR, and ATLAS-2M studies.